ANTARES PHARMA INC's ticker is and the CUSIP is 36642956. A total of 1 filers reported holding ANTARES PHARMA INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $179,000 | -20.4% | 105,200 | -2.9% | 0.00% | -33.3% |
| Q2 2015 | $225,000 | +102.7% | 108,300 | +164.8% | 0.00% | +50.0% |
| Q1 2015 | $111,000 | +2.8% | 40,900 | -2.4% | 0.00% | 0.0% |
| Q4 2014 | $108,000 | +28.6% | 41,900 | -8.7% | 0.00% | +100.0% |
| Q3 2014 | $84,000 | -40.0% | 45,900 | -12.2% | 0.00% | -50.0% |
| Q2 2014 | $140,000 | -63.4% | 52,300 | -52.1% | 0.00% | -66.7% |
| Q1 2014 | $382,000 | -41.8% | 109,100 | -25.5% | 0.01% | -40.0% |
| Q4 2013 | $656,000 | +47.7% | 146,400 | +33.9% | 0.01% | +11.1% |
| Q3 2013 | $444,000 | – | 109,300 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 146,400 | $656,000 | 0.01% |